Overview

A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression

Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
To assess the comparative efficacy of sertraline versus venlafaxine XR on measures of quality of life.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Sertraline
Venlafaxine Hydrochloride